Photocure appoints Genotests as exclusive partner for Hexvix[ ]in Chile
(WorldNews Canada)

Photocure appoints Genotests as exclusive partner for Hexvix[ ]in Chile 13.08.2020 11:48 https://newsweb.oslobors.no/message/511165 Oslo, Norway, 13 August 2020: Photocure ASA (OSE: PHO), today announced the appointment of Genotests SpA as the exclusive distributor for the commercialization of Hexvix[®] in Chile. `We are proud to take our first step into the South American continent and make Hexvix accessible to Chilean bladder cancer patients. Chile is a stable, well regulated market with a strong economy, and Genotests is well positioned to leverage their network of urologists and uro-oncologists both in the private and public hospitals`, says Dan Schneider, President and CEO of Photocure....